Impact of Model for End-Stage Liver Disease Score on Long-Term Survival Following Liver Transplantation for Hepatocellular Carcinoma
β Scribed by Roma, J.; Balbi, E.; Pacheco-Moreira, L.; Zyngier, I.; Araujo, A.; Agoglia, L.; Steinbruck, K.; Velaverde, L.G.; Martinho, J.M.
- Book ID
- 119382677
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 270 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
It has been suggested that hepatitis C virus (HCV) patients with hepatocellular carcinoma (HCC) may have worse outcomes after liver transplantation (LT) because of more aggressive tumor biology. In this study, we determined the post-LT survival of HCC patients with and without HCV using United Netwo
The objective of this study was to predict postoperative liver failure and morbidity after hepatectomy for hepatocellular carcinoma (HCC) with cirrhosis. The model for end-stage liver disease (MELD) score is currently accepted as a disease severity index of cirrhotic patients awaiting liver transpla